rs72650053

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001267550.2(TTN):​c.36625G>T​(p.Val12209Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0107 in 1,588,700 control chromosomes in the GnomAD database, including 1,337 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/14 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. V12209V) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.014 ( 57 hom., cov: 29)
Exomes 𝑓: 0.010 ( 1280 hom. )

Consequence

TTN
NM_001267550.2 missense

Scores

10

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: -0.385

Publications

5 publications found
Variant links:
Genes affected
TTN (HGNC:12403): (titin) This gene encodes a large abundant protein of striated muscle. The product of this gene is divided into two regions, a N-terminal I-band and a C-terminal A-band. The I-band, which is the elastic part of the molecule, contains two regions of tandem immunoglobulin domains on either side of a PEVK region that is rich in proline, glutamate, valine and lysine. The A-band, which is thought to act as a protein-ruler, contains a mixture of immunoglobulin and fibronectin repeats, and possesses kinase activity. An N-terminal Z-disc region and a C-terminal M-line region bind to the Z-line and M-line of the sarcomere, respectively, so that a single titin molecule spans half the length of a sarcomere. Titin also contains binding sites for muscle associated proteins so it serves as an adhesion template for the assembly of contractile machinery in muscle cells. It has also been identified as a structural protein for chromosomes. Alternative splicing of this gene results in multiple transcript variants. Considerable variability exists in the I-band, the M-line and the Z-disc regions of titin. Variability in the I-band region contributes to the differences in elasticity of different titin isoforms and, therefore, to the differences in elasticity of different muscle types. Mutations in this gene are associated with familial hypertrophic cardiomyopathy 9, and autoantibodies to titin are produced in patients with the autoimmune disease scleroderma. [provided by RefSeq, Feb 2012]
TTN-AS1 (HGNC:44124): (TTN antisense RNA 1) This gene encodes a non-coding RNA transcribed from the opposite strand to the titin gene. [provided by RefSeq, Aug 2016]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0014425218).
BP6
Variant 2-178663341-C-A is Benign according to our data. Variant chr2-178663341-C-A is described in ClinVar as Benign. ClinVar VariationId is 192214.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.122 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TTNNM_001267550.2 linkc.36625G>T p.Val12209Leu missense_variant Exon 173 of 363 ENST00000589042.5 NP_001254479.2 A0A0A0MTS7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TTNENST00000589042.5 linkc.36625G>T p.Val12209Leu missense_variant Exon 173 of 363 5 NM_001267550.2 ENSP00000467141.1 A0A0A0MTS7

Frequencies

GnomAD3 genomes
AF:
0.0142
AC:
2075
AN:
146308
Hom.:
56
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.0167
Gnomad AMI
AF:
0.00347
Gnomad AMR
AF:
0.00514
Gnomad ASJ
AF:
0.0214
Gnomad EAS
AF:
0.130
Gnomad SAS
AF:
0.0404
Gnomad FIN
AF:
0.0241
Gnomad MID
AF:
0.00637
Gnomad NFE
AF:
0.00320
Gnomad OTH
AF:
0.0151
GnomAD2 exomes
AF:
0.0234
AC:
5452
AN:
232644
AF XY:
0.0239
show subpopulations
Gnomad AFR exome
AF:
0.0186
Gnomad AMR exome
AF:
0.00453
Gnomad ASJ exome
AF:
0.0244
Gnomad EAS exome
AF:
0.162
Gnomad FIN exome
AF:
0.0270
Gnomad NFE exome
AF:
0.00412
Gnomad OTH exome
AF:
0.0194
GnomAD4 exome
AF:
0.0103
AC:
14884
AN:
1442274
Hom.:
1280
Cov.:
34
AF XY:
0.0113
AC XY:
8135
AN XY:
716784
show subpopulations
African (AFR)
AF:
0.0161
AC:
527
AN:
32706
American (AMR)
AF:
0.00417
AC:
175
AN:
41944
Ashkenazi Jewish (ASJ)
AF:
0.0230
AC:
593
AN:
25740
East Asian (EAS)
AF:
0.141
AC:
5380
AN:
38058
South Asian (SAS)
AF:
0.0418
AC:
3424
AN:
81834
European-Finnish (FIN)
AF:
0.0270
AC:
1431
AN:
52930
Middle Eastern (MID)
AF:
0.0166
AC:
68
AN:
4086
European-Non Finnish (NFE)
AF:
0.00211
AC:
2332
AN:
1105440
Other (OTH)
AF:
0.0160
AC:
954
AN:
59536
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
535
1070
1606
2141
2676
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
190
380
570
760
950
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0142
AC:
2084
AN:
146426
Hom.:
57
Cov.:
29
AF XY:
0.0158
AC XY:
1126
AN XY:
71140
show subpopulations
African (AFR)
AF:
0.0167
AC:
658
AN:
39296
American (AMR)
AF:
0.00514
AC:
74
AN:
14406
Ashkenazi Jewish (ASJ)
AF:
0.0214
AC:
73
AN:
3410
East Asian (EAS)
AF:
0.130
AC:
607
AN:
4654
South Asian (SAS)
AF:
0.0405
AC:
171
AN:
4224
European-Finnish (FIN)
AF:
0.0241
AC:
245
AN:
10182
Middle Eastern (MID)
AF:
0.00685
AC:
2
AN:
292
European-Non Finnish (NFE)
AF:
0.00322
AC:
216
AN:
67094
Other (OTH)
AF:
0.0175
AC:
35
AN:
2004
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.578
Heterozygous variant carriers
0
68
136
205
273
341
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0112
Hom.:
21
Bravo
AF:
0.0134
ESP6500AA
AF:
0.0226
AC:
39
ESP6500EA
AF:
0.00455
AC:
18
ExAC
AF:
0.0270
AC:
3229

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jun 26, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 28797094) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:2
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jun 24, 2013
Biesecker Lab/Clinical Genomics Section, National Institutes of Health
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

- -

Autosomal recessive limb-girdle muscular dystrophy type 2J Benign:1
Sep 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal recessive limb-girdle muscular dystrophy type 2J;C1858763:Dilated cardiomyopathy 1G Benign:1
Jan 20, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Early-onset myopathy with fatal cardiomyopathy Benign:1
Sep 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Tibial muscular dystrophy Benign:1
Sep 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Myopathy, myofibrillar, 9, with early respiratory failure Benign:1
Sep 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.67
T
BayesDel_noAF
Benign
-0.61
CADD
Benign
4.0
DANN
Benign
0.84
Eigen
Benign
-0.43
Eigen_PC
Benign
-0.52
FATHMM_MKL
Benign
0.049
N
LIST_S2
Benign
0.69
T
MetaRNN
Benign
0.0014
T
MetaSVM
Benign
-1.1
T
PhyloP100
-0.39
Vest4
0.058
MPC
0.21
ClinPred
0.0024
T
GERP RS
2.4
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs72650053; hg19: chr2-179528068; COSMIC: COSV59894987; COSMIC: COSV59894987; API